drugset / Trial / NCT00003578

High Dose Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Intermediate- or High-Grade Non-Hodgkin's Lymphoma

NCT00003578

Phase 3 Unknown 500 enrolled Lymphoma Trials Office
RandomizedTreatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Bone marrow transplantation may allow doctors to give higher doses of chemotherapy drugs and kill more cancer cells. It is not yet known whether high dose chemotherapy plus bone marrow transplantation is more effective than high dose chemotherapy alone for intermediate- or high-grade non-Hodgkin's lymphoma. PURPOSE: Randomized phase III trial to compare the effectiveness of high dose chemotherapy with or without bone marrow transplantation in treating patients who have intermediate- or high-grade non-Hodgkin's lymphoma.

Timeline

Start
1993-01
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Cytarabine Small molecule Intravenous
Subject Etoposide Small molecule Intravenous
Subject Melphalan Small molecule Intravenous
Subject carmustine Small molecule Intravenous
Background Cyclophosphamide Other / unclassified
Background Doxorubicin Other / unclassified
Background Prednisone Other / unclassified
Background Vincristine Small molecule

Indications